Head-to-head
Eden vs Ro
Eden and Ro both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
Eden
Higher scoreRanked #2 · Grade B+
Best for: Parents who want a transparent, well-run async program with both molecules and don't mind paying above the cheapest tiers for a tidy experience.
Visit EdenRo
Ranked #5 · Grade B
Best for: Parents who specifically want brand-name medication and insurance help, and will trade a fast, price-first decision for a bigger clinical apparatus.
Visit RoThe verdict
Eden edges out Ro on the Rx-Readiness Score, 89 to 86 (B+ vs B). Parents who want a transparent, well-run async program with both molecules and don't mind paying above the cheapest tiers for a tidy experience.
Ro is still a genuine option — a heavyweight platform with brand-name access and insurance navigation — powerful if you want FDA-approved product, but the compounded pricing is opaque and can slow a quick decision. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Eden | Ro |
|---|---|---|
| Rx-Readiness Score | 89/100 · B+ | 86/100 · B |
| Overall rank | #2 | #5 |
| Semaglutide | $239/mo | Not disclosed |
| Tirzepatide | $349/mo | Not disclosed |
| Coverage | All 50 states | Multi-state |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Eden
Ranked #2 · Grade B+
What we like
- Clear flat pricing and a straightforward async signup — no drawn-out scheduling
- Both semaglutide and tirzepatide, available in all 50 states
- Strong up-front disclosure, so there are fewer surprises after you commit
The caveats
- Premium sticker price versus the budget tiers
- Compounded only — no brand-name lane
- No oral route for the needle-averse
Ro
Ranked #5 · Grade B
What we like
- Brand-name (Wegovy/Zepbound) access plus insurance navigation
- Oral options and a well-funded, polished platform
- Deep clinical infrastructure for a more involved path
The caveats
- Compounded pricing isn't posted up front — hard to compare fast
- Insurance and brand routes add steps, not speed
- Premium positioning overall
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing Eden and Ro against other providers on our shortlist.
Or browse the full comparison hub.